Phase III KEYNOTE-789: PemetrexedPlatinum Chemotherapy ±

platinum 789ALTERNATIF LINK PLATINUM 789. LINK ALTERNATIF. Share link. close button. ?ref=CS2ABAH00AJ&utm_medium=social&utm_source=heylinkFinal analysis of the phase III KEYNOTE-789 trial evaluating pemetrexedplatinum chemotherapy with or without pembrolizumab in TKI-resistant, EGFR-mutated, metastatic